Skip to main content
Contact Us
Subscribe
E-Edition
62°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by ENDRA Life Sciences Inc.
< Previous
1
2
Next >
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 28, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024
March 21, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Installs First TAEUS System in the UK
February 27, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS System
February 21, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe
February 14, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology
November 29, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference
November 27, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
November 14, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents
November 08, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023
November 07, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD’s The Liver Meeting® 2023
November 06, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023
September 07, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA
August 30, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents
August 23, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update
August 14, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA
August 14, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023
August 01, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Announces Adjournment of 2023 Annual Meeting of Stockholders to July 25, 2023
July 06, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
Study Highlighting ENDRA Life Sciences’ TAEUS Technology to be Presented at EASL International Liver Congress 2023
June 07, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update
May 15, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Report First Quarter 2023 Financial Results on May 15, 2023
May 04, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Announces Closing of Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Securities
May 02, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Announces Pricing of Upsized $4.5 Million Public Offering
April 28, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 14, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 14, 2023
March 07, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Announces 1-for-20 Reverse Stock Split
December 05, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update
November 14, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Report Third Quarter 2022 Financial Results on November 14, 2022
November 09, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of Two U.S. Patents
October 25, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Participate in the H.C. Wainwright 6th Annual NASH Investor Conference
October 04, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.